Catalyst Biosciences is a biopharmaceutical company that offers protease therapeutics to address disorders of the coagulation system.
Industries BiopharmaBiotechnologyLife SciencePharmaceuticalDiversity Spotlight (US Headquarters Only) Women FoundedHeadquarters Regions San Francisco Bay Area, West Coast, Western US Founded Date 1997 Founders Charles S. Craik, Christopher Thanos, Jack Nguyen, Sandra Waugh Ruggles Operating Status Active Last Funding Type Post-IPO Equity Also Known As Targacept, Inc. Legal Name Catalyst Biosciences, Inc.
Stock Symbol NASDAQ:CBIO Company Type For Profit
Contact Email info@catbio.com Phone Number +1 650 871 0761
Catalyst Biosciences is a research and clinical development biopharmaceutical company. They focus on addressing unmet medical needs in rare disorders of the complement and coagulation systems. They create novel catalytic biopharmaceutical products based on engineered human proteases.